Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

被引:29
|
作者
Gama, Clarissa Severino [1 ,2 ,3 ,4 ]
Berk, Michael [3 ,5 ,6 ]
Andreazza, Ana Cristina [1 ,2 ,7 ]
Kapczinski, Flavio [1 ,2 ,7 ]
Belmonte-de-Abreu, Paulo [1 ,2 ,4 ]
机构
[1] Hosp Clin Porto Alegre, Res Ctr, Mol Psychiat Lab, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Grad Program Med Psychiat, Porto Alegre, RS, Brazil
[3] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia
[4] Hosp Clin Porto Alegre, Schizophrenia Program, BR-90035003 Porto Alegre, RS, Brazil
[5] Orygen Res Ctr, Parkville, Vic, Australia
[6] Mental Hlth Res Inst, Parkville, Vic, Australia
[7] Hosp Clin Porto Alegre, Bipolar Disorders Program, BR-90035003 Porto Alegre, RS, Brazil
关键词
Schizophrenia; Brain-derived neurotrophic factor; Superoxide dismutase; Thiobarbituric acid reactive substances; Nerve growth factors;
D O I
10.1590/S1516-44462008000400006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The neurotrophins, antioxidant enzymes and oxidative markers have reciprocal interactions. This report verified in chronically stable medicated schizophrenic patients whether there are correlations between the serum levels of superoxide dismutase, a key enzyme in the antioxidant defense, thiobarbituric acid reactive substances, a direct index of lipid peroxidation, and brain-derived neurotrophic factor, the most widely distributed neurotrophin. Method: Sixty DSM-IV schizophrenic patients were included (43 males, 17 females). Mean age was 34.7 +/- 10.8 years, mean age at first episode was 19.8 +/- 7.9 years, and mean illness duration was 14.9 +/- 8.5 years. Each subject had a blood sample collected for the determination of serum levels of brain-derived neurotrophic factor, thiobarbituric acid reactive substances and superoxide dismutase. Results: Brain-derived neurotrophic factor levels showed a positive correlation with thiobarbituric acid reactive substances levels (r = 0.333, p = 0.009). Brain-derived neurotrophic factor levels were not correlated with superoxide dismutase levels (r = - 0.181, p = 0.166), and superoxide dismutase levels were not correlated with thiobarbituric acid reactive substances levels (r = 0.141, p = 0.284). Conclusions: The positive correlation between brain-derived neurotrophic factor and thiobarbituric acid reactive substances suggests the need of further investigation on intracellular interactions of neurotrophins, antioxidant enzymes and oxidative markers. In addition, this opens a venue for investigation on treatments for the prevention of neurotoxicity along the course of schizophrenia.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [31] Serum brain derived neurotrophic factor levels in schizophrenic patients treated with olanzapine and clozapine
    Pirildar, S
    Taneli, F
    Mete, L
    Gonul, AS
    Kucuk, O
    Zorlu, N
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S492 - S492
  • [32] Effects of olanzapine on plasma levels of monoamine metabolites and brain-derived neurotrophic factor in schizophrenic patients
    Hori, Hikaru
    Yoshimura, Reiji
    Utsunomiya, Kensuke
    Mitoma, Masae
    Yamada, Yasuhisa
    Kakihara, Shingo
    Shinkai, Koji
    Ueda, Nobuhisa
    Nakamura, Jun
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A1 - A1
  • [33] Agomelatine antidepressant activity and serum concentration of brain-derived neurotrophic factor (BDNF): a positive correlation
    Martinotti, G.
    Di Giannantonio, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S394 - S395
  • [34] Comparison of Serum Brain-Derived Neurotrophic Factor Levels in Diabetic Patients With and Without Retinopathy
    Rashid, Romana R.
    Fazal, Ayesha
    Khan, Qudsia U.
    Misbah-ul-Qamar, Dr
    Ahmed, Farooq
    Laique, Talha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [35] Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders
    Nakazato, M
    Hashimoto, K
    Shimizu, E
    Kumakiri, C
    Koizumi, H
    Okamura, N
    Mitsumori, M
    Komatsu, N
    Iyo, M
    BIOLOGICAL PSYCHIATRY, 2003, 54 (04) : 485 - 490
  • [36] Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism
    Hashimoto, Kenji
    Iwata, Yasuhide
    Nakamura, Kazuhiko
    Tsujii, Masatsugu
    Tsuchiya, Kenji J.
    Sekine, Yoshimoto
    Suzuki, Katsuaki
    Minabe, Yoshio
    Takei, Nori
    Yo, Masaomi
    Mori, Norio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (08): : 1529 - 1531
  • [37] Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression
    Nomoto, Hiroshi
    Baba, Hajime
    Satomura, Emi
    Maeshima, Hitoshi
    Takebayashi, Naoko
    Namekawa, Yuki
    Suzuki, Toshihito
    Arai, Heii
    BMC PSYCHIATRY, 2015, 15
  • [38] Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression
    Hiroshi Nomoto
    Hajime Baba
    Emi Satomura
    Hitoshi Maeshima
    Naoko Takebayashi
    Yuki Namekawa
    Toshihito Suzuki
    Heii Arai
    BMC Psychiatry, 15
  • [39] Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants
    Huang, Tiao-Lai
    Lee, Chien-Te
    Liu, Yu-Li.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (07) : 521 - 525
  • [40] Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder
    Videira Dias, Vasco
    Brissos, Sofia
    Frey, Benicio N.
    Andreazza, Ana Cristina
    Cardoso, Carlos
    Kapczinski, Flavio
    BIPOLAR DISORDERS, 2009, 11 (06) : 663 - 671